Design and Evaluation of an In-Vehicle Real-Time Drunk Driving Detection System (DRIVE)

April 2, 2026 updated by: University of Bern

Randomized, Controlled, Interventional Single-Centre Study for the Design and Evaluation of an In-Vehicle Real-Time Drunk Driving Detection System - The DRIVE Test Track Study

To analyze driving behavior of individuals under the influence of alcohol while driving in a real car. Based on the in-vehicle variables, the investigators aim at establishing algorithms capable of discriminating sober and drunk driving using machine learning.

Study Overview

Detailed Description

Driving under the influence of alcohol (or "drunk driving") is one of the most significant causes of traffic accidents. Alcohol consumption impairs neurocognitive and psychomotor function and has been shown to be associated with an increased risk of driving accidents. However, autonomous driving (level 4 or 5) is likely to be broadly available only at a substantially later time point than previously thought due to increasing concerns of safety associated with this technology. Therefore, solutions bridging the upcoming time period by more rapidly and directly addressing the problem of drunk driving associated traffic incidents are urgently needed.

On the supposition that driving behavior differs significantly between sober state and drunk state, the investigators assume that different driving patterns of people under alcohol influence compared to sober states can be used to generate drunk driving detection models using machine learning algorithms. In this study, driving for data collection is initially performed at a sober baseline state (no alcohol) and then after alcohol administration (with a target of 0.15 mg/l and 0.35 mg/l breath alcohol concentration).

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3008
        • Institut für Rechtsmedizin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Informed consent as documented by signature.
  • In possession of a definite Swiss or EU driving license.
  • At least 21 years old
  • Active driving in the last 6 months.
  • No special equipment needed when driving.
  • Drinks alcohol at least occasionally (moderate/social consumption).
  • Fluent in (Swiss) German and no speech impairment.

Exclusion Criteria:

  • Health concerns that are incompatible with alcohol consumption.
  • Any potential participant currently taking illegal drugs or medications that interact with alcohol.
  • Women who are pregnant or breast feeding.
  • Intention to become pregnant during the course of the study.
  • Teetotallers (alcohol abstinent persons).
  • Alcohol misuse (excessive alcohol consumption habits/risky drinking behaviour (according to WHO definition) and/or the biomarker PEth in capillary blood > 200 ng/mL at first visit.
  • Known or suspected drug abuse within 4 weeks before the study (e.g., positive urine drug test at first visit).
  • Non-compliance to alcohol abstinence within 24 hours before the study visits.
  • Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. of the participant.
  • Participation in another study with investigational drug within the 30 days preceding and during the present study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment Group

Driving under the influence of alcohol

Aware of the possible induction of alcohol (purpose of the study), but blinded to the actual amount and target blood alcohol concentration

Participants will drive in three different states (sober, drunk above and below the legal limit) on a designated circuit with a real car on a test track accompanied by a driving instructor. After the initial sober driving session, participants are administered pre-mixed alcoholic beverages (e.g., vodka orange). Participants are expected to achieve a target breath alcohol concentration of 0.35 mg/l (legal limit in Switzerland is 0.25 mg/l breath alcohol concentration) before the second driving session starts. Finally, the third driving session starts when the participants' breath alcohol concentration drops to 0.15 mg/l.

Participants will be blinded to their alcohol levels during the study.

Measurements: Heart rate, respiration rate, blood oxygen saturation, skin conductance, skin temperature, accelerometer, eye movement, radar, facial expression, audio recording, vehicle data, in-cabin gas concentration

No Intervention: Reference Group

Driving without the influence of alcohol or placebo

Fully informed

Placebo Comparator: Placebo Group

Driving under the influence of a placebo

Not informed (blinded)

Participants will drive three times at the same intervals as the treatment group on a designated circuit with a real car on a test track accompanied by a driving instructor. After the initial driving session, participants receive placebo beverages (e.g., orange juice with vodka flavor).

Participants are fully blinded.

Measurements: Heart rate, respiration rate, blood oxygen saturation, skin conductance, skin temperature, accelerometer, eye movement, radar, facial expression, audio recording, vehicle data, in-cabin gas concentration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic accuracy of the drunk driving warning system (DRIVE) to detect states of alcohol influence while driving quantified as the Area Under the Receiver Operator Characteristics Curve (AUROC)
Time Frame: 480 minutes
The machine learning model is developed and evaluated based on in-vehicle data generated in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC.
480 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic accuracy of the drunk driving warning system using physiological data to detect states of alcohol influence quantified as the Area Under the Receiver Operator Characteristics Curve (AUROC)
Time Frame: 480 minutes
The machine learning model is developed and evaluated based on physiological wearable data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC.
480 minutes
Diagnostic accuracy of the drunk driving warning system using eye-tracking data to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
The machine learning model is developed and evaluated based on eye-tracking data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC.
480 minutes
Diagnostic accuracy of the drunk driving warning system using controller area network data of the study car to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
The machine learning model is developed and evaluated based on controller area network data of the study car recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC.
480 minutes
Diagnostic accuracy of the drunk driving warning system using audio data to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
The machine learning model is developed and evaluated based on audio data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC.
480 minutes
Diagnostic accuracy of the drunk driving warning system using radar sensor data to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
The machine learning model is developed and evaluated based on radar sensor data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC.
480 minutes
Diagnostic accuracy of the drunk driving warning system using gas sensor data to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
The machine learning model is developed and evaluated based on gas sensor data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC.
480 minutes
Change of steering over the alcohol intoxication trajectory
Time Frame: 480 minutes
Steering is recorded based on the controller area network.
480 minutes
Change of steer torque over the alcohol intoxication trajectory
Time Frame: 480 minutes
Steer torque is recorded based on the controller area network.
480 minutes
Change of steer speed over the alcohol intoxication trajectory
Time Frame: 480 minutes
Steer speed is recorded based on the controller area network.
480 minutes
Change of velocity over the alcohol intoxication trajectory
Time Frame: 480 minutes
Velocity is recorded based on the controller area network.
480 minutes
Change of acceleration over the alcohol intoxication trajectory
Time Frame: 480 minutes
Acceleration is recorded based on the controller area network.
480 minutes
Change of braking over the alcohol intoxication trajectory
Time Frame: 480 minutes
Braking is recorded based on the controller area network.
480 minutes
Change of swerving over the alcohol intoxication trajectory
Time Frame: 480 minutes
Swerving is recorded based on the controller area network.
480 minutes
Change of spinning over the alcohol intoxication trajectory
Time Frame: 480 minutes
Spinning is recorded based on the controller area network.
480 minutes
Change of gaze position over the alcohol intoxication trajectory
Time Frame: 480 minutes
Gaze position is recorded using an eye-tracker device.
480 minutes
Change of gaze velocity over the alcohol intoxication trajectory
Time Frame: 480 minutes
Gaze velocity is recorded using an eye-tracker device.
480 minutes
Change of gaze acceleration over the alcohol intoxication trajectory
Time Frame: 480 minutes
Gaze acceleration is recorded using an eye-tracker device.
480 minutes
Change of gaze regions of interest over the alcohol intoxication trajectory
Time Frame: 480 minutes
Gaze regions of interest (e.g., windshield, car dashboard, etc.) are recorded using an eye-tracker device.
480 minutes
Change of gaze events over the alcohol intoxication trajectory
Time Frame: 480 minutes
Gaze events (e.g., fixations, saccades, etc.) are recorded using an eye-tracker device.
480 minutes
Change of head pose over the alcohol intoxication trajectory
Time Frame: 480 minutes
Head pose (position/rotation) is recorded using an eye-tracker device.
480 minutes
Change of heart rate over the alcohol intoxication trajectory
Time Frame: 480 minutes
Heart rate is recorded using a heart rate monitoring device and wearables.
480 minutes
Change of heart rate variability over the alcohol intoxication trajectory
Time Frame: 480 minutes
Heart rate variability is recorded using a heart rate monitoring device and wearables.
480 minutes
Change of electrodermal activity over the alcohol intoxication trajectory
Time Frame: 480 minutes
Electrodermal activity is recorded using wearables.
480 minutes
Change of wrist accelerometer measurements over the alcohol intoxication trajectory
Time Frame: 480 minutes
Wrist accelerometer measurements are recorded using wearables.
480 minutes
Change of skin temperature over the alcohol intoxication trajectory
Time Frame: 480 minutes
Skin temperature is recorded using wearables.
480 minutes
Self-assessment of driving performance over the alcohol intoxication trajectory
Time Frame: 480 minutes
Participants rate their driving performance on a 7-point Likert Scale (lower value means poorer driving performance).
480 minutes
Self-estimation of alcohol concentrations over the alcohol intoxication trajectory
Time Frame: 480 minutes
Participants estimate their blood alcohol concentration.
480 minutes
Number of driving mishaps over the alcohol intoxication trajectory
Time Frame: 480 minutes
Any driving mishaps, accidents and interventions by the driving instructor will be documented.
480 minutes
Number of Adverse Events (AEs)
Time Frame: 3 months, from screening to close out visit for each participant
Adverse Events will be recorded at each study visit.
3 months, from screening to close out visit for each participant
Number of Serious Adverse Events (SAEs)
Time Frame: 3 months, from screening to close out visit for each participant.
Serious Adverse Events will be recorded at each study visit.
3 months, from screening to close out visit for each participant.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wolfgang Weinmann, Prof. Dr., University of Bern

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 5, 2023

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

March 8, 2023

First Submitted That Met QC Criteria

March 20, 2023

First Posted (Actual)

April 3, 2023

Study Record Updates

Last Update Posted (Actual)

April 3, 2026

Last Update Submitted That Met QC Criteria

April 2, 2026

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Drinking

Clinical Trials on Driving under the influence of alcohol

Subscribe